The Sex of Cells Matter: Renowned expert in women’s health, Sarah Berga, MD, discusses why industry must consider sex differences in drug development.
Wake Forest’s Paul Laurienti, MD, PhD, is studying how starlings relate to complex human brain networks. Read more.
Our scientists are developing tomorrow’s innovations in therapeutics, vaccines, medical devices and more. Get updates from Wake Forest Innovations.
Charles Branch, Jr., M.D., professor and chair of neurosurgery at Wake Forest, is a new breed of scientist: part clinician, part investigator, and full-bore innovator.
The nasal cannula gets its first redesign since the 1960s. A Wake Forest orbital surgeon envisions a safer way to deliver oxygen. Explore the novel design of the dual-port nasal cannula.
Read an interview with Eric Tomlinson, DSc, PhD, about how Wake Forest Innovations accelerates innovation in the development of health care products.
Wake Forest Innovations offers an extensive portfolio of technology licensing opportunities in biomedical and materials science.
Wake Forest Innovations supports your R&D needs through easy access to Wake Forest's unique research capabilities.
Wake Forest Innovations drives the creation of a new hub for innovation in biomedical and materials science and information technology.
A change is under way at university tech transfer offices (TTOs) across the United States. Schools are expanding their TTO teams, shifting their business aims and changing their models. The focus is moving to startup companies and proactive outreach to the private sector. What are the factors behind these changes, and how are academic institutions continue reading
Earlier this year Donald Spector, Chairman of the Board at New York College, and one of the most prolific inventors in the world, got a patent for biosensor signals that are transmitted from Smartphones to third party agencies. Spector envisioned this technology even before there were Smartphones and has one of the earliest known patents continue reading